Loading candles…
Linde India Limited operates in the industrial gases, medical gases, and engineering industries within India. The company manufactures industrial and medical gases, including medical oxygen, and constructs both cryogenic and non-cryogenic air separation plants. It functions through two main business segments: Gases, Related Products & Services and the Project Engineering Division (PED). Its product offerings encompass pipeline, liquefied, and compressed industrial gases as well as specialized engineering solutions for air separation and nitrogen plants. Linde India Limited is a subsidiary of Linde plc and the BOC Group, UK, which holds a 75% stake in the company.
This page is a live market overview for LINDE INDIA LIMITED (LINDEINDIA) on the NSE. As a listed security, LINDE INDIA LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LINDEINDIA before placing trades on tick2trade.
As of the latest feed, LINDEINDIA last traded at ₹7,112.5 on NSE, down ₹40 (0.56%) from the previous close of ₹7,152.5. Today's session range is ₹7,057 – ₹7,206, against a 52-week band of ₹5,673 – ₹8,049. Traded volume today stands at 20.72K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for LINDEINDIA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LINDEINDIA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for LINDE INDIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LINDEINDIA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LINDEINDIA option chain page linked from this overview.
| Audited Results - Q4 & FY26 |
| This is to inform you that a meeting of the Board of Directors of the Company has been scheduled to be held on Saturday, 30 May 2026, to inter-alia, consider… |
| 30 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 9 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2025 | 6 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June 2025 | 7 Aug 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31 March 2025 | 23 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.